TY - JOUR
T1 - Breast implant-associated anaplastic large cell lymphoma
T2 - emotional impact and guidelines for psychological support
AU - Oliveri, Serena
AU - Ongaro, Giulia
AU - Durosini, Ilaria
AU - Curigliano, Giuseppe
AU - Pravettoni, Gabriella
N1 - Funding Information:
Dr. Oliveri work on this article was supported by the grant from The Swedish Foundation for Humanities and Social Sciences, which had no influence on the content of this paper. Grant no. M13-0260:1.
Funding Information:
The authors are grateful to The Swedish Foundation for Humanities and Social Sciences supporting this contribution. Dr Ilaria Durosini was supported by Fondazione Umberto Veronesi.
Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Purpose: During the last two decades, the number of breast implants used in aesthetic, oncologic, and risk-reducing surgery has increased substantially mainly due to the improvement and confirmed safety of these devices. Since the identification of the first case of anaplastic large cell lymphoma associated with a breast implant (BIA-ALCL) 20 years ago, there has been an increase in the number of reports of this very rare disease, demonstrating a clear association with breast implants. While the majority of cases are localized and cured by implant removal and full capsulectomy, a small percentage require chemotherapy and the mortality rate is very low. Nevertheless, the evidence linking BIA-ALCL to implant surface texturing has raised concerns about the long-term safety of these devices resulting in patient and regulatory authority concerns globally. Methods and Results: In this commentary, we report the current debate on BIA-ALCL and the main European government’s actions, with a special focus on the emotional impact that media coverage has on cancer patients. We comment the emotional impact of such risk for patients with breast implant, the hard process of patient’s acceptance for mastectomy and reconstructive surgery, and how this is an essential part of recovery and return to the normal living for many women. Conclusion: We conclude by providing guidelines for patient–physician communication and patients’ psychological support on this topic of delicate actuality. Our contribution aims at guiding the medical community in managing risk communication about BIA-ALCL with a multidisciplinary approach, according to the most recently available published evidence.
AB - Purpose: During the last two decades, the number of breast implants used in aesthetic, oncologic, and risk-reducing surgery has increased substantially mainly due to the improvement and confirmed safety of these devices. Since the identification of the first case of anaplastic large cell lymphoma associated with a breast implant (BIA-ALCL) 20 years ago, there has been an increase in the number of reports of this very rare disease, demonstrating a clear association with breast implants. While the majority of cases are localized and cured by implant removal and full capsulectomy, a small percentage require chemotherapy and the mortality rate is very low. Nevertheless, the evidence linking BIA-ALCL to implant surface texturing has raised concerns about the long-term safety of these devices resulting in patient and regulatory authority concerns globally. Methods and Results: In this commentary, we report the current debate on BIA-ALCL and the main European government’s actions, with a special focus on the emotional impact that media coverage has on cancer patients. We comment the emotional impact of such risk for patients with breast implant, the hard process of patient’s acceptance for mastectomy and reconstructive surgery, and how this is an essential part of recovery and return to the normal living for many women. Conclusion: We conclude by providing guidelines for patient–physician communication and patients’ psychological support on this topic of delicate actuality. Our contribution aims at guiding the medical community in managing risk communication about BIA-ALCL with a multidisciplinary approach, according to the most recently available published evidence.
KW - BIA-ALCL
KW - Breast prostheses
KW - Decision-making
KW - Personalized medicine
KW - Psychological support
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=85082966192&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082966192&partnerID=8YFLogxK
U2 - 10.1007/s10549-020-05601-w
DO - 10.1007/s10549-020-05601-w
M3 - Article
C2 - 32232699
AN - SCOPUS:85082966192
VL - 181
SP - 221
EP - 224
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
SN - 0167-6806
IS - 1
ER -